01 22Gowling WLG (Canada) LLP
01 62573586
02 42813849
03 62813900
04 63116725
01 22SECUKINUMAB
01 4POWDER FOR SOLUTION
02 18SOLUTION
01 11931-10-07
02 21931-11-04
03 62025-08-04
04 52031-10-07
05 82031-11-04
Patent Expiration Date : 1931-11-04
Date Granted : 2023-10-24
Brand Name : COSENTYX
Patent Number : 3116725
Filing Date : 2011-11-04
Strength per Unit : 150mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 1931-11-04
Date Granted : 2023-10-24
Patent Expiration Date : 2025-08-04
Date Granted : 2013-06-25
Brand Name : COSENTYX
Patent Number : 2573586
Filing Date : 2005-08-04
Strength per Unit : 150mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2025-08-04
Date Granted : 2013-06-25
Patent Expiration Date : 1931-11-04
Date Granted : 2021-06-15
Brand Name : COSENTYX
Patent Number : 2813849
Filing Date : 2011-11-04
Strength per Unit : 150mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 1931-11-04
Date Granted : 2021-06-15
Patent Expiration Date : 1931-10-07
Date Granted : 2017-01-10
Brand Name : COSENTYX
Patent Number : 2813900
Filing Date : 2011-10-07
Strength per Unit : 150mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 1931-10-07
Date Granted : 2017-01-10
Patent Expiration Date : 2025-08-04
Date Granted : 2013-06-25
Brand Name : COSENTYX
Patent Number : 2573586
Filing Date : 2005-08-04
Strength per Unit : 150 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2025-08-04
Date Granted : 2013-06-25
Patent Expiration Date : 2025-08-04
Date Granted : 2013-06-25
Brand Name : COSENTYX
Patent Number : 2573586
Filing Date : 2005-08-04
Strength per Unit : 150 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2025-08-04
Date Granted : 2013-06-25
Patent Expiration Date : 2031-10-07
Date Granted : 2017-01-10
Brand Name : COSENTYX
Patent Number : 2813900
Filing Date : 2011-10-07
Strength per Unit : 150 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2031-10-07
Date Granted : 2017-01-10
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-10-07
Date Granted : 2017-01-10
Brand Name : COSENTYX
Patent Number : 2813900
Filing Date : 2011-10-07
Strength per Unit : 150 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2031-10-07
Date Granted : 2017-01-10
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-11-04
Date Granted : 2021-06-15
Brand Name : COSENTYX
Patent Number : 2813849
Filing Date : 2011-11-04
Strength per Unit : 150 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2031-11-04
Date Granted : 2021-06-15
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-11-04
Date Granted : 2023-10-24
Brand Name : COSENTYX
Patent Number : 3116725
Filing Date : 2011-11-04
Strength per Unit : 150 mg / vial
Dosage Form : POWDER FOR SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2031-11-04
Date Granted : 2023-10-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
